These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2970949

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of teicoplanin in the elderly.
    Rosina R, Villa G, Danese A, Cavenaghi L, Picardi L, Salvadeo A.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():39-45. PubMed ID: 2965130
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers.
    Smithers JA, Kulmala HK, Thompson GA, Antony KK, Lewis EW, Ruberg SJ, Kenny MT, Dulworth JK, Brackman MA.
    Antimicrob Agents Chemother; 1992 Jan; 36(1):115-20. PubMed ID: 1534211
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment.
    Bonati M, Traina GL, Rosina R, Buniva G.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of 14C-teicoplanin in healthy volunteers.
    Buniva G, Del Favero A, Bernareggi A, Patoia L, Palumbo R.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():23-8. PubMed ID: 2965128
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function.
    Derbyshire N, Webb DB, Roberts D, Glew D, Williams JD.
    J Antimicrob Chemother; 1989 Jun; 23(6):869-76. PubMed ID: 2527223
    [Abstract] [Full Text] [Related]

  • 10. Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing.
    Guay DR, Awni WM, Halstenson CE, Kenny MT, Keane WF, Matzke GR.
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2012-5. PubMed ID: 2532874
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of teicoplanin in man after intravenous administration.
    Traina GL, Bonati M.
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):119-28. PubMed ID: 6238156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of teicoplanin in burn patients.
    Potel G, Moutet J, Bernareggi A, Le Normand Y, Meigner M, Baron D.
    Scand J Infect Dis Suppl; 1990 Apr; 72():29-34. PubMed ID: 2151064
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
    Granneman GR, Sennello LT, Steinberg FJ, Sonders RC.
    Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.